Post-intensive care syndrome: its pathophysiology, prevention, and future directions.
Shigeaki Inoue, Junji Hatakeyama, Yutaka Kondo...
https://pubmed.ncbi.nlm.nih.gov/31304024/Actively Recruiting
Led by Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa · Updated on 2026-04-13
7000
Participants Needed
7
Research Sites
52 weeks
Total Duration
Persistent Critical Illness PCI affects some patients who stay in the Intensive Care Unit ICU for a long time, usually more than 10 to 14 days. It occurs in about 5 to 20% of critically ill patients and is linked to ongoing life support needs like mechanical ventilation or blood pressure medications. This study aims to identify different clinical patterns among adult ICU patients who remain in the ICU for more than 10 days to help improve personalized care strategies. The research involves a multicenter retrospective cohort of adults aged 18 years or older who were admitted to participating ICUs and stayed for more than 5 days between 2021 and 2023. Data collected will include patient demographics, clinical and laboratory information, details on organ support such as mechanical ventilation and vasopressors, medications, nutrition, and rehabilitation practices. Statistical and machine learning methods will be used to find groups of patients with similar clinical courses and relate these groups to outcomes. Participants data will be followed until hospital discharge and up to one year if available. The study will measure the need for continuous organ support at day 10 in the ICU as the primary outcome. Secondary outcomes include mortality rates and organ dysfunction based on the identified PCI clusters. This observational study will provide insights into PCI recovery and long-term disability, aiming to develop tailored management strategies for different patient profiles.
CONDITIONS
UP STUDY - Decipher Persistent Critical Illness Through in Deep Clinical Phenotyping.
S
Susana Fernandes, MD PhD.
M
Mariana Santos, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Lead Sponsor
Centro Hospitalar de Vila Nova de Gaia/Espinho
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants who remain in the ICU for more than 5 days are eligible.
Duration - First 10 days in the ICU
Participants are observed during their ICU stay to identify persistent critical illness and assess organ support needs.
Daily assessments during ICU stay
Duration - Up to 1 year post ICU discharge
Participants are followed after ICU stay to monitor mortality and organ dysfunction up to 1 year.
Follow-up visits depending on hospital discharge and availability
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Shigeaki Inoue, Junji Hatakeyama, Yutaka Kondo...
https://pubmed.ncbi.nlm.nih.gov/31304024/David A Harrison, Ben C Creagh-Brown, Kathryn M Rowan
https://pubmed.ncbi.nlm.nih.gov/37260430/Matthew Cadd, Maya Nunn
https://pubmed.ncbi.nlm.nih.gov/33743819/Ena Gupta, Mitchell D Jacobs, Gautam George...
https://pubmed.ncbi.nlm.nih.gov/30849230/Rui Antunes Pereira, Marta Sousa, José Pedro Cidade...
https://pubmed.ncbi.nlm.nih.gov/36888823/Kristina E Fuest, Bernhard Ulm, Nils Daum...
https://pubmed.ncbi.nlm.nih.gov/36597110/Süleyman Yildirim, Yusuf Durmaz, Yosun Şan...
https://pubmed.ncbi.nlm.nih.gov/34177170/Martin Shaw, Elizabeth M Viglianti, Joanne McPeake...
https://pubmed.ncbi.nlm.nih.gov/32426744/L F Span, A R Hermus, A K Bartelink...
https://pubmed.ncbi.nlm.nih.gov/1613205/Guillaume Voiriot, Mehdi Oualha, Alexandre Pierre...
https://pubmed.ncbi.nlm.nih.gov/35779142/Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Lead Sponsor
Centro Hospitalar de Vila Nova de Gaia/Espinho
Collaborating Sponsor